Table 3—

Changes in clinical and metabolic characteristics from baseline to years 1 and 3

From baseline to year 1
From baseline to year 3
Intervention groupControl groupP*Intervention groupControl groupP*
n256250231203
Weight
 kg−4.5 ± 5.0−1.0 ± 3.7<0.0001−3.5 ± 5.1−0.9 ± 5.4<0.0001
 %−5.1 ± 5.3−1.1 ± 4.2<0.0001−4.0 ± 5.8−1.1 ± 6.2<0.0001
BMI (kg/m2)−1.6 ± 1.8−0.4 ± 1.3<0.0001−1.3 ± 1.9−0.3 ± 2.0<0.0001
Waist circumference (cm)−4.4 ± 5.2−1.3 ± 4.8<0.0001−3.3 ± 5.7−1.2 ± 5.90.0005
Fasting plasma glucose (mmol/l)−0.2 ± 0.70.0 ± 0.7<0.0001−0.0 ± 0.70.1 ± 0.70.0664
2-h plasma glucose (mmol/l)−0.9 ± 1.9−0.3 ± 2.20.001−0.5 ± 2.4−0.1 ± 2.20.0664
HbA1c (%)−0.1 ± 0.70.1 ± 0.60.0003−0.2 ± 0.60.0 ± 0.60.002
Serum total cholesterol (mmol/l)−0.1 ± 0.7−0.1 ± 0.70.5097−0.1 ± 0.90.1 ± 0.80.0712
Serum HDL cholesterol (mmol/l)0.05 ± 0.190.02 ± 0.170.06810.14 ± 0.200.11 ± 0.190.1354
Serum total cholesterol–to–HDL cholesterol ratio−0.4 ± 0.8−0.1 ± 0.80.0011−0.6 ± 0.9−0.3 ± 0.80.0009
Serum triglycerides (mmol/l)−0.2 ± 0.6−0.0 ± 0.7<0.0001−0.1 ± 0.6−0.0 ± 0.80.024
  • Data are means ± SD.

  • * ANCOVA adjusting for baseline value. Values in bold are statistically significant.